• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症在多个种族和民族群体中的发病率。

Incidence of multiple sclerosis in multiple racial and ethnic groups.

机构信息

Department of Research and Evaluation, Kaiser Permanente, Southern California, Pasadena, CA, USA.

出版信息

Neurology. 2013 May 7;80(19):1734-9. doi: 10.1212/WNL.0b013e3182918cc2.

DOI:10.1212/WNL.0b013e3182918cc2
PMID:23650231
Abstract

OBJECTIVE

To determine whether the incidence of multiple sclerosis (MS) varies by race/ethnicity in a multiethnic, population-based cohort.

METHODS

We conducted a retrospective cohort study of more than 9 million person-years of observation from the multiethnic, community-dwelling members of Kaiser Permanente Southern California health plan from January 1, 2008 to December 31, 2010. Incidence of MS and risk ratios comparing incidence rates between racial/ethnic groups were calculated using Poisson regression.

RESULTS

We identified 496 patients newly diagnosed with MS who met McDonald criteria. The average age at diagnosis was 41.6 years (range 8.6-78.3 years) and 70.2% were women. The female preponderance was more pronounced among black (79.3%) than white, Hispanic, and Asian individuals with MS (67.8%, 68.1%, and 69.2%, respectively; p = 0.03). The incidence of MS was higher in blacks (10.2, 95% confidence interval [CI] 8.4-12.4; p < 0.0001) and lower in Hispanics (2.9, 95% CI 2.4-3.5; p < 0.0001) and Asians (1.4, 95% CI 0.7-2.4; p < 0.0001) than whites (6.9, 95% CI 6.1-7.8). Black women had a higher risk of MS (risk ratio 1.59, 95% CI 1.27-1.99; p = 0.0005) whereas black men had a similar risk of MS (risk ratio 1.04, 95% CI = 0.67-1.57) compared with whites.

CONCLUSIONS

Our findings do not support the widely accepted assertion that blacks have a lower risk of MS than whites. A possible explanation for our findings is that people with darker skin tones have lower vitamin D levels and thereby an increased risk of MS, but this would not explain why Hispanics and Asians have a lower risk of MS than whites or why the higher risk of MS among blacks was found only among women.

摘要

目的

在一个多民族的基于人群的队列中,确定多发性硬化症(MS)的发病率是否因种族/民族而异。

方法

我们对 2008 年 1 月 1 日至 2010 年 12 月 31 日期间,来自 Kaiser Permanente 南加州健康计划的多民族、社区居住成员的超过 900 万人年的观察进行了回顾性队列研究。使用泊松回归计算 MS 的发病率和比较不同种族/民族组发病率的风险比。

结果

我们发现了 496 名符合麦克唐纳标准的新诊断为 MS 的患者。诊断时的平均年龄为 41.6 岁(范围 8.6-78.3 岁),70.2%为女性。患有 MS 的黑人(79.3%)比白人、西班牙裔和亚裔女性的女性优势更为明显(67.8%、68.1%和 69.2%,分别;p=0.03)。黑人的 MS 发病率较高(10.2,95%置信区间[CI]8.4-12.4;p<0.0001),西班牙裔(2.9,95%CI2.4-3.5;p<0.0001)和亚裔(1.4,95%CI0.7-2.4;p<0.0001)的发病率较低。白人(6.9,95%CI6.1-7.8)。黑人女性患 MS 的风险更高(风险比 1.59,95%CI1.27-1.99;p=0.0005),而黑人男性患 MS 的风险与白人相似(风险比 1.04,95%CI=0.67-1.57)。

结论

我们的研究结果不支持黑人患 MS 的风险低于白人的普遍观点。我们研究结果的一个可能解释是,肤色较深的人维生素 D 水平较低,因此患 MS 的风险增加,但这并不能解释为什么西班牙裔和亚裔患 MS 的风险低于白人,或者为什么黑人患 MS 的风险较高仅在女性中发现。

相似文献

1
Incidence of multiple sclerosis in multiple racial and ethnic groups.多发性硬化症在多个种族和民族群体中的发病率。
Neurology. 2013 May 7;80(19):1734-9. doi: 10.1212/WNL.0b013e3182918cc2.
2
The incidence of clinically isolated syndrome in a multi-ethnic cohort.多民族队列中临床孤立综合征的发病率。
J Neurol. 2014 Jul;261(7):1349-55. doi: 10.1007/s00415-014-7349-0. Epub 2014 Apr 29.
3
Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas.不同种族和族裔群体中结膜黑色素瘤的基于人群的发病率及其与其他黑色素瘤的比较。
Am J Ophthalmol. 2008 Mar;145(3):418-423. doi: 10.1016/j.ajo.2007.10.022. Epub 2008 Jan 11.
4
Socioeconomic position, race/ethnicity, and inflammation in the multi-ethnic study of atherosclerosis.动脉粥样硬化多民族研究中的社会经济地位、种族/族裔与炎症
Circulation. 2007 Nov 20;116(21):2383-90. doi: 10.1161/CIRCULATIONAHA.107.706226.
5
The effect of race and ethnicity on kidney allograft outcome.种族和族裔对肾移植结果的影响。
Clin Transpl. 1995:379-94.
6
Racial and Ethnic Disparities in Multiple Sclerosis Prevalence.多发性硬化症患病率的种族和民族差异。
Neurology. 2022 May 3;98(18):e1818-e1827. doi: 10.1212/WNL.0000000000200151.
7
MS Sunshine Study: Sun Exposure But Not Vitamin D Is Associated with Multiple Sclerosis Risk in Blacks and Hispanics.阳光研究:暴露在阳光下而不是维生素 D 与黑人和西班牙裔的多发性硬化症风险相关。
Nutrients. 2018 Feb 27;10(3):268. doi: 10.3390/nu10030268.
8
Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases.种族和民族对药物洗脱支架和裸金属支架治疗结果的影响:国家心血管数据注册中心和医疗保险和医疗补助服务支付者数据库中 423965 例患者的结果。
Circulation. 2013 Apr 2;127(13):1395-403. doi: 10.1161/CIRCULATIONAHA.113.001437.
9
Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain.西班牙加那利群岛拉斯帕尔马斯多发性硬化症的患病率和发病率
Neuroepidemiology. 2005;24(1-2):70-5. doi: 10.1159/000081052. Epub 2004 Sep 24.
10
Sex and racial/ethnic disparities in outcomes after acute myocardial infarction: a cohort study among members of a large integrated health care delivery system in northern California.急性心肌梗死后结局的性别及种族/民族差异:一项对北加利福尼亚州一个大型综合医疗保健服务系统成员的队列研究。
Arch Intern Med. 2005 Oct 10;165(18):2105-13. doi: 10.1001/archinte.165.18.2105.

引用本文的文献

1
Health disparities in neurology.神经病学中的健康差异。
Nat Rev Neurol. 2025 Sep 10. doi: 10.1038/s41582-025-01134-2.
2
A Cross-Sectional Study of Delayed Diagnosis Associated with Gender and Racial Identity in Multiple Sclerosis.一项关于多发性硬化症中与性别和种族身份相关的延迟诊断的横断面研究。
J Racial Ethn Health Disparities. 2025 Sep 5. doi: 10.1007/s40615-025-02611-6.
3
Genetic Association and Causal Effects Between Obesity and Multiple Sclerosis: A Robust Two-Sample Mendelian Randomization Study.肥胖与多发性硬化症之间的遗传关联及因果效应:一项稳健的两样本孟德尔随机化研究
Cureus. 2025 Aug 3;17(8):e89287. doi: 10.7759/cureus.89287. eCollection 2025 Aug.
4
Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies.儿童多发性硬化症:通过高效疗法改善预后。
Neurotherapeutics. 2025 Jul;22(4):e00631. doi: 10.1016/j.neurot.2025.e00631. Epub 2025 Jun 27.
5
B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry.与非洲裔多发性硬化症患者抗CD20治疗后早期免疫重建相关的B细胞外在和内在因素。
Front Immunol. 2025 Jun 10;16:1590165. doi: 10.3389/fimmu.2025.1590165. eCollection 2025.
6
Factors associated with delay to diagnosis of multiple sclerosis in Zambia.赞比亚多发性硬化症诊断延迟的相关因素。
Mult Scler. 2025 Aug;31(9):1039-1050. doi: 10.1177/13524585251344832. Epub 2025 Jun 17.
7
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USA.美国使用富马酸盐治疗的黑人、西班牙裔、亚裔和白人多发性硬化症患者的真实世界治疗结果
Neurol Ther. 2025 Jun 16. doi: 10.1007/s40120-025-00773-3.
8
Embodiment of structural racism and multiple sclerosis risk and outcomes in the USA.美国结构性种族主义与多发性硬化症风险及结局的体现
Nat Rev Neurol. 2025 May 27. doi: 10.1038/s41582-025-01096-5.
9
Influence of race and gender on variability in clinical decision-making in neurology.种族和性别对神经病学临床决策变异性的影响。
Sci Rep. 2025 May 23;15(1):17882. doi: 10.1038/s41598-025-00726-8.
10
Racial Inequities, Multiple Sclerosis, and Implementation of a Novel Treatment Algorithm at the Health System Level.种族不平等、多发性硬化症以及卫生系统层面新型治疗算法的实施
Neurology. 2025 May 27;104(10):e213607. doi: 10.1212/WNL.0000000000213607. Epub 2025 Apr 21.